See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct.17, 2002

Migraine and Cluster Headaches Pancreatic Cancer Diabetes Mellitus Types I and II

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch.

Migraine and Cluster Headaches

Study physicians are conducting research into an already approved [oral] anti-migraine medication in the form of a nasal spray. This investigational nasal spray is being evaluated to determine whether it effectively and more rapidly reduces migraine pain. Research sites throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat100.html.

-----

Pancreatic Cancer

An open-label, randomized, controlled, phase III, multi-centered, clinical trial of PN401 with High Dose 5-Fluorouracil (5-FU) versus Gemcitabine for treatment of patients with Advanced Pancreatic Cancer. Research site in Duarte, California.

More Information

Please see http://www.centerwatch.com/patient/studies/cat35.html.

-----

Diabetes Type I

Research study of an investigational form of Inhaled Insulin for individuals 18-65 years of age with Type I Diabetes. Research site in Renton, Washington.

More Information

Please see http://www.centerwatch.com/patient/studies/cat55.html.

-----

Copyright 2002 Centerwatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.